|
|
 Originally Posted by wufwugy
For these countries with monopolized healthcare:
What happens to the incentive for investors to take on big risky projects with potential payoff of creating new therapies that solve unsolved problems?
The projects are not run by state medical staff, they're run either by universities or private corporations. Monopolized healthcare (come on, should have been easy to come up with a more derogatory and dismissive term for it) does not include basic research, drug development nor production. So, not much I would think.
Here's which countries put out the most research per capita:
|
Reply With Quote